Dónal Landers

8PUBLICATIONS
87CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesEmergency medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

Emily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck

|Jan 19, 2023
Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials.

Paul O'Regan, Richard Hoskins, Christopher Grave

|Jan 17, 2023
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.

R C Coombes, P D Badman, J P Lozano-Kuehne

|Jun 10, 2022
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.

R C Coombes, P D Badman, J P Lozano-Kuehne

|May 24, 2022
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital.

Rebecca J Lee, Oskar Wysocki, Cong Zhou

|Feb 16, 2022
Biomarker identification using dynamic time warping analysis: a longitudinal cohort study of patients with COVID-19 in a UK tertiary hospital.

Hannah Burke, Anna Freeman, Paul O'Regan

Pageof 2

Frequent Collaborators

2 joint publications

R C Coombes

2 joint publications

P D Badman

2 joint publications

J P Lozano-Kuehne

2 joint publications

I R Macpherson